Overview

Study About Effect of Saxagliptin on Circulating Endothelial Progenitor Cells and Endothelial Function in Newly Diagnosed Type 2 Diabetic Patients

Status:
Completed

Trial end date:
2015-07-01

Target enrollment:

Participant gender:

Summary

In this study, the investigators aim to investigate whether saxagliptin modulate endothelial progenitor cells number and flow-mediated dilation in newly diagnosed, treatment-naive type 2 diabetic patients.

Phase:

Phase 4

Details

Lead Sponsor:

Shanghai Zhongshan Hospital

Collaborator:

Chinese Medical Association

Treatments:

Metformin
Saxagliptin